Advertisement

Topics

Cameron Health Subcutaneous Implantable Defibrillator (S-ICD) System Patient Registry (CHIP)

2014-08-27 03:15:17 | BioPortfolio

Summary

This objective of this study is to confirm the long-term safety and effectiveness of the subcutaneous implantable defibrillator (S-ICD) System.

Description

This registry will collect long-term data to further characterize the continued safety and performance of the S-ICD System. Patients implanted with a CE Marked S-ICD System, not participating in the Cameron Health's IDE clinical study will be enrolled in this registry. This study is designed to be a post-implant registry, and patients are meant to be seen in accordance with the institution's standard of care.

The primary objective of this registry is to track patient demographic and longitudinal data on the use and function of the S-ICD System. A secondary objective is to evaluate long-term performance through an evaluation of spontaneous episodes.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

Tachycardia, Ventricular

Intervention

S-ICD System

Location

Christchurch Hospital
Christchurch
New Zealand

Status

Not yet recruiting

Source

Cameron Health, Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:15:17-0400

Clinical Trials [614 Associated Clinical Trials listed on BioPortfolio]

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction

The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart fa...

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

To demonstrate that scar-based ventricular tachycardia (VT) ablation using the FlexAbility™ ablation catheter system results in a superior clinical outcome compared to routine drug thera...

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

The objective of this clinical investigation is to evaluate the safety and efficacy of the CyberHeart System in patients with refractory ventricular tachycardia (VT). The ablation will be...

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or ...

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with ...

PubMed Articles [9380 Associated PubMed Articles listed on BioPortfolio]

Prognostic Significance of Non-Sustained Ventricular Tachycardia Depends on Its Rate and DurationNon-sustained ventricular tachycardia episodes predict future hospitalization in ICD recipients with heart failure.

Association of Regional Epicardial Right Ventricular Electrogram Voltage Amplitude and Late Gadolinium Enhancement Distribution on Cardiac Magnetic Resonance in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Implications for Ventricular Tachycardia Ablation.

Criteria for identification of anatomic ventricular tachycardia (VT) substrates in arrhythmogenic right ventricular cardiomyopathy (ARVC) on late gadolinium enhancement (LGE) cardiac magnetic resonanc...

Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).

The VANISH trial (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease) compared the effectiveness of escalated antiarrhythmic drug therapy to cathet...

Cerebral Protection During Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease.

Catheter ablation of ventricular tachycardia (VT) is associated with the risk of cerebral embolism. The origin of periprocedural brain embolism in the setting of VT ablation is often unknown and strat...

Atrioventricular nodal re-entrant tachycardia mimicking ventricular tachycardia on the surface electrocardiogram.

Medical and Biotech [MESH] Definitions

Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.

An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.

Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003)

A potentially lethal cardiac arrhythmia characterized by an extremely rapid, hemodynamically unstable ventricular tachycardia (150-300 beats/min) with a large oscillating sine-wave appearance. If untreated, ventricular flutter typically progresses to VENTRICULAR FIBRILLATION.

More From BioPortfolio on "Cameron Health Subcutaneous Implantable Defibrillator (S-ICD) System Patient Registry (CHIP)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Searches Linking to this Trial